AI Analysis AI Analysis of GRFS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add GRFS to Watchlist?
Some Reasons Why To Add GRFS:
  • Attractive free cash flow ratio of 8.8x
  • Solid financial health (Piotroski 5/9)
  • Strong operating margin of 16.9%
PDF

Grifols stock upgraded from Hold/Accumulate to Buy Candidate after Wednesday trading session
(Updated on Jul 22, 2026)

Buy or Hold candidate since Jul 20, 2026 Gain 3.55%

The Grifols stock price gained 1.68% on the last trading day (Wednesday, 22nd Jul 2026), rising from $7.75 to $7.88. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 1.60% from a day low at $7.81 to a day high of $7.93. The price has been going up and down for this period, and there has been a 7.8% gain for the last 2 weeks. Volume fell on the last day by -118 thousand shares and in total, 380 thousand shares were bought and sold for approximately $2.99 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

Given the current short-term trend, the stock is expected to fall -11.24% during the next 3 months and, with a 90% probability hold a price between $6.14 and $6.99 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

GRFS Signals & Forecast

Mostly positive signals in the chart today. The Grifols stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $7.44 and $7.37. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, July 14, 2026, and so far it has risen 12.25%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Grifols stock

On the downside, the stock finds support just below today's level from accumulated volume at $7.33 and $7.21. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Grifols finds support just below today's level at $7.33. If this is broken, then the next support from accumulated volume will be at $7.21 and $7.08.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.125 (1.60%) between high and low. For the last week, the stock has had daily average volatility of 2.25%.

The Grifols stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought and the RSI is still moving upwards. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely, and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $7.65 (-2.96%) (This stock has low daily movements and this gives low risk. The RSI14 is 77 and this increases the risk substantially. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (GRFS) For The Upcoming Trading Day Of Thursday 23rd

For the upcoming trading day on Thursday, 23rd we expect Grifols to open at $7.87, and during the day (based on 14 day Average True Range), to move between $7.78 and $7.98, which gives a possible trading interval of +/-$0.192 (+/-2.47%) up or down from last closing price. If Grifols takes out the full calculated possible swing range there will be an estimated 2.47% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $7.98 (1.27%) than the support at $7.33 (6.98%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

Grifols will release earnings BMO on Tuesday, July 28, 2026.The consensus among the analysts for the expected earnings (EPS) is $0.280. We will update the financials statements for Grifols, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 6.19% in the first trading day after earnings release.

Is Grifols stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 2.135 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 23, 2026 - $7.87 ( 0.106%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

GRFS Performance

Trading levels for GRFS

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 8.00 1.48%
R2 7.95 0.87%
R1 7.92 0.500%
Price 7.88
S1 7.82 -0.712%
S2 7.79 -1.09%
S3 7.75 -1.69%

Accumulated Volume Support & Resistance Levels

Level Price
R3 8.19 3.93%
R2 8.06 2.28%
R1 7.98 1.27%
Price 7.88
S1 7.33 -6.98%
S2 7.21 -8.50%
S3 7.08 -10.15%

GRFS Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jul 02, 2026 Jul 02, 2026 Jul 09, 2026 $0.0765 1.06%
2 Jul 30, 2025 Aug 12, 2025 Aug 20, 2025 $0.140 1.30%
3 May 26, 2021 Jun 03, 2021 Jun 14, 2021 $0.456 2.48%
4 Oct 22, 2020 Oct 30, 2020 Nov 09, 2020 $0.201 1.03%
5 Oct 31, 2019 Dec 02, 2019 Dec 11, 2019 $0.220 0.97%

FAQ

What is the symbol for Grifols Stock and on which exchange is it traded?
The symbol for Grifols is GRFS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Grifols Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

How to buy Grifols Stock?
Grifols Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Grifols Stock.

What's the current price of Grifols Stock?
As of the end of day on the Jul 22, 2026, the price of an Grifols (GRFS) share was $7.88.

What is the 52-week high and low for Grifols Stock?
The 52-week high for Grifols Stock is $11.13 and the 52-week low is $6.96.

What is the market capitalization of Grifols Stock?
As of the Jul 22, 2026, the market capitalization of Grifols is 6.666B.

When is the next earnings date for Grifols?
The upcoming earnings date for Grifols is Jul 28, 2026.
Click to get the best stock tips daily for free!
ABOUT GRIFOLS
Grifols
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunogl...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
6.70% Jul 13
JLL
$299.78
8.23% Jun 24
ROP
$331.60
5.76% Jun 24
NMRK
$15.02
4.79% Jun 24
CAG
$13.43
10.69% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE